Cargando…
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS)
BACKGROUND: In patients with multiple sclerosis (MS), relapses and disability progression have been associated with decreased health-related quality of life (HRQoL). METHODS: PROTYS, a prospective, multicentre, single-arm, observational study in seven Swiss MS centres, evaluated correlations between...
Autores principales: | Achtnichts, Lutz, Zecca, Chiara, Findling, Oliver, Kamm, Christian P, Mueller, Stefanie, Kuhle, Jens, Lutterotti, Andreas, Gobbi, Claudio, Viviani, Camille, Villiger-Borter, Emanuela, Nedeltchev, Krassen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884862/ https://www.ncbi.nlm.nih.gov/pubmed/36727105 http://dx.doi.org/10.1136/bmjno-2022-000304 |
Ejemplares similares
-
Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod
por: Diem, Lara, et al.
Publicado: (2018) -
A comparison of balance control during stance and gait in patients with inflammatory and non-inflammatory polyneuropathy
por: Findling, Oliver, et al.
Publicado: (2018) -
Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis
por: Achtnichts, Lutz, et al.
Publicado: (2021) -
SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot
por: Achtnichts, Lutz, et al.
Publicado: (2022) -
Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
por: Friend, Susan, et al.
Publicado: (2016)